Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 69
Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary References Anderson, J. L., B. D. Horne, S. M. Stevens, A. S. Grove, S. Barton, Z. P. Nicholas, S. F. Kahn, H. T. May, K. M. Samuelson, J. B. Muhlestein, and J. F. Carlquist. 2007. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anti-coagulation. Circulation 116(22):2563-2570. Burke, W., and R. L. Zimmern. 2004. Ensuring the appropriate use of genetic tests. Nat Rev Genet 5(12):955-959. Califf, R. M. 2004. Defining the balance of risk and benefit in the era of genomics and proteomics. Health Aff (Millwood) 23(1):77-87. Califf, R. M., and G. S. Ginsburg. 2008. Organizational improvements to enhance modern clinical epidemiology. JAMA 300(19):2300-2302. Califf, R. M., E. D. Peterson, R. J. Gibbons, A. Garson, Jr., R. G. Brindis, G. A. Beller, and S. C. Smith, Jr. 2002. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol 40(11):1895-1901. CDC (Centers for Disease Control and Prevention). 2007. ACCE: A CDC-sponsored project carried out by the foundation of blood research. http://cdc.gov/genomics/gtesting/ACCE.htm (accessed June 1, 2009). Davis, R. L., and M. J. Khoury. 2006. A public health approach to pharmacogenomics and gene-based diagnostic tests. Pharmacogenomics 7(3):331-337. Djulbegovic, B., and B. Bercu. 2002. At what level of collective equipoise does a clinical trial become ethical for the IRB members? Paper presented at USF Third National Symposium, Bioethical Considerations in Human Subject Research, Clearwater, FL. March 8. Djulbegovic, B., A. Frohlich, and C. L. Bennett. 2005. Acting on imperfect evidence: How much regret are we ready to accept? J Clin Oncol 23(28):6822-6825. EGAPP (Evaluation of Genomic Applications in Practice and Prevention). 2009. Working group: Recommendations. http://www.egappreviews.org/workingrp/recommendations.htm (accessed May 27, 2009). Ginsburg, G. S. 2009. Duke guided genomic studies. Presentation at Institute of Medicine workshop, Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health, Irvine, CA. February 12.
OCR for page 70
Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary Ginsburg, G. S., and J. J. McCarthy. 2001. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol 19(12):491-496. Goldstein, D. B. 2009. Common Genetic Variation and Human Traits. N Engl J Med 360(17): 1696-1698. Grosse, S. D., and M. J. Khoury. 2006. What is the clinical utility of genetic testing? Genet Med 8(7):448-450. Gudgeon, J. M., M. R. McClain, G. E. Palomaki, and M. S. Williams. 2007. Rapid ACCE: Experience with a rapid and structured approach for evaluating gene-based testing. Genet Med 9(7):473-478. Haddow, J. E., and G. E. Palomaki. 2004. ACCE: A model process for evaluating data on emerging genetic tests. In Human genome epidemiology: A scientific foundation for using genetic information to improve health and prevent disease, edited by M. J. Khoury, J. Little, and W. Burke. New York: Oxford University Press. Pp. 217-233. Hardy, J., and A. Singleton. 2009. Genome Wide Association Studies and Human Disease. N Engl J Med 360(17):1759-1768. IOM (Institute of Medicine). 2006. Genes, Behavior, and the Social Environment: Moving Beyond the Nature/Nurture Debate. Washington, DC: The National Academies Press. ———. 2008. Diffusion and Use of Genomic Innovations in Health and Medicine. Washington, DC: The National Academies Press. ———. 2009. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research. Washington, DC: The National Academies Press. Kaufman, D., J. Murphy, L. Erby, K. Hudson, and J. Scott. 2009. Veterans’ attitudes regarding a database for genomic research. Genet Med 11(5):329-337. Khoury, M. J., A. Berg, R. Coates, J. Evans, S. M. Teutsch, and L. A. Bradley. 2008. The evidence dilemma in genomic medicine. Health Aff (Millwood) 27(6):1600-1611. Mallal, S., E. Phillips, G. Carosi, J. M. Molina, C. Workman, J. Tomazic, E. Jagel-Guedes, S. Rugina, O. Kozyrev, J. F. Cid, P. Hay, D. Nolan, S. Hughes, A. Hughes, S. Ryan, N. Fitch, D. Thorborn, and A. Benbow. 2008. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358(6):568-579. Muralidhar, S. 2009. Veterans administration. Presentation at Institute of Medicine workshop, Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health, Irvine, CA. February 12. Phillips, K. A. 2006. The intersection of biotechnology and pharmacogenomics: Health policy implications. Health Aff (Millwood) 25(5):1271-1280. ———. 2008. Closing the evidence gap in the use of emerging testing technologies in clinical practice. JAMA 300(21):2542-2544. Potti, A., S. Mukherjee, R. Petersen, H. K. Dressman, A. Bild, J. Koontz, R. Kratzke, M. A. Watson, M. Kelley, G. S. Ginsburg, M. West, D. H. Harpole, Jr., and J. R. Nevins. 2006. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355(6):570-580. Smith, D. J., and A. J. Lusis. 2009. Genomic Approaches to Complex Disease. Genomic and Personalized Medicine, edited by H. F. Willard and G. S. Ginsburg. Oxford, UK: Elsevier, Inc. Tavris, D. R., B. A. Gallauresi, S. Dey, R. Brindis, and K. Mitchel. 2007. Risk of local adverse events by gender following cardiac catheterization. Pharmacoepidemiol Drug Saf 16(2):125-131. Teutsch, S. M. 2009, February 12. Does the type of decision being made influence the evidence needed? Presentation at Institute of Medicine workshop, Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health, Irvine, CA, February 12. Teutsch, S. M., and M. L. Berger. 2005. Evidence synthesis and evidence-based decision making: Related but distinct processes. Med Decis Making 25(5):487-489.
OCR for page 71
Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary Teutsch, S. M., L. A. Bradley, G. E. Palomaki, J. E. Haddow, M. Piper, N. Calonge, W. D. Dotson, M. P. Douglas, and A. O. Berg. 2009. The evaluation of genomic applications in practice and prevention (EGAPP) initiative: Methods of the EGAPP working group. Genet Med 11(1):3-14. Williams, M., and G. Wood. 2009. Estimating the prevalence of hereditary hemorrhagic telangiectasia (HHT) in patients with juvenile polyposis (JP) using a clinical informatics system. J Investig Med 57(116):A68.
OCR for page 72
Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary This page intentionally left blank.